- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.08. | PROVECTUS BIOPHARMACEUTICALS, INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 30.06. | Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals and VisiRose Announce U.S. Patent Award for Light-Independent Antibacterial Eye Drop Targeting Drug-Resistant Ocular Infections | 198 | GlobeNewswire (Europe) | New IP covers topical rose bengal sodium ophthalmic composition against MRSA and other resistant Gram-positive bacteria without requiring light activation. VisiRose to hold exclusive ophthalmic license.... ► Artikel lesen | |
| 25.06. | Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Launches Veripure, an Open Science Program for Medical Research Access to PV-10 (rose bengal sodium) | 191 | GlobeNewswire (Europe) | Under Veripure, Provectus is supplying qualified medical researchers with the same pharmaceutical grade rose bengal sodium API used in clinical trials.Veripure is also a quality benchmark, distinguishing... ► Artikel lesen | |
| 18.06. | PROVECTUS BIOPHARMACEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| PROVECTUS Aktie jetzt für 0€ handeln | |||||
| 18.05. | Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Reports Oral PV-10 Anti-Tumor Activity in Preclinical Bladder Cancer Study; Long-Term Survivors Show Absence of Gross Bladder Tumor at Study End | 831 | GlobeNewswire (Europe) | Long-term survivors in both oral PV-10 arms showed an absence of gross bladder tumor at necropsy, a finding not observed in any untreated, vehicle-control, or anti-PD-1 monotherapy animal. KNOXVILLE... ► Artikel lesen | |
| 04.05. | Provectus Biopharmaceuticals Inc.: Bascom Palmer Eye Institute Presents Four Posters on Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2026, Advancing the Clinical Case for Provectus's VisiRose Subsidiary and Rose Bengal Sodium in ... | 1 | GlobeNewswire (USA) |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 35,000 | +0,57 % | Der große Alzheimer-Wettlauf: Wie Eisai, Novo Nordisk, Regeneron, Alnylam und NeuroThera fünf völlig verschiedene Angriffspunkte wählen | ||
| AURORA CANNABIS | 3,604 | +2,10 % | Curaleaf Holdings, Inc.: Curaleaf Challenges Aurora's Unilateral Rejection of Its Enhanced Proposal | STAMFORD, Conn., Oct. 19, 2026 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer... ► Artikel lesen | |
| CANOPY GROWTH | 0,610 | +1,16 % | Trump's Marijuana Order Is Stuck at the DEA. Here's What That Means for Canopy Growth. | ||
| TILRAY BRANDS | 2,575 | -1,15 % | Tilray Brands, Inc.: West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers | ELLON, Scotland and LONDON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- BrewDog, a leader in U.K. craft beer and one of the world's most recognised beer brands, owned by Tilray Brands, Inc. (NASDAQ: TLRY... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 465,45 | -0,33 % | 115 Millionen US-Dollar mit einer Zelltherapie: Warum Mesoblast, Vertex und NurExone Zellen und Exosomen unterschiedlich nutzen | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -2- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameCA83013Q8719 CORE... ► Artikel lesen | |
| CRONOS GROUP | 3,072 | +1,92 % | Cronos Group Inc: Cronos Group completes CanAdelaar acquisition | ||
| DIGICANN VENTURES | 0,006 | 0,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,813 | 0,00 % | Aurora Cannabis: Organigram funkt Curaleaf dazwischen | ||
| GREEN THUMB INDUSTRIES | 5,720 | -1,89 % | President Trump's Push to Reschedule Marijuana Hit a Snag. Is Green Thumb Still a Buy? | ||
| SINOPHARM | 1,742 | -1,69 % | SINOPHARM (01099): ANNOUNCEMENT PRELIMINARY FINANCIAL DATA OF SINOPHARM ACCORD FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2026 | ||
| NOVERIS HEALTH SCIENCES | 0,032 | 0,00 % | Noveris Health Sciences Inc.: Noveris Health Sciences Announces Results of 2026 Annual General and Special Meeting | Vancouver, British Columbia--(Newsfile Corp. - September 9, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces the results of its annual... ► Artikel lesen | |
| ASSEMBLY BIOSCIENCES | 18,640 | +2,42 % | Assembly Biosciences: Warum die Phase-1a-Daten nicht reichen | ||
| CSPC PHARMA | 0,922 | -7,09 % | Dividendenbekanntmachungen (20.10.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERICAN TOWER CORPORATION US03027X1000 1,79 USD EUR ANHUI CONCH CEMENT CO LTD ADR US0352431045 0,096 USD EUR ANTIN INFRASTRUCTURE... ► Artikel lesen | |
| SANTHERA PHARMACEUTICALS | 15,560 | -2,63 % | Santhera steigert Umsatz im H1 markant und verringert Verlust | Pratteln - Das Biopharmaunternehmen Santhera hat im ersten Halbjahr den Umsatz markant gesteigert. Unter dem Strich konnte gleichzeitig der Verlust deutlich eingegrenzt werden. Getragen wird die Firma... ► Artikel lesen |
PROVECTUS BIOPHARMACEUTICALS INC gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROVECTUS BIOPHARMACEUTICALS INC finden Sie auf Wallstreet Online.